HCAR2 and atherosclerosis: Despite the usefulness of niacin in the treatment of atherosclerosis, patient compliance is greatly weakened by cutaneous flushing, caused by HCAR2 triggering the release of vasodilatory prostaglandins from Langerhans cells and keratinocytes14,15.